Prognosis of Japanese Metastatic Renal Cell Carcinoma Patients in the Cytokine Era: A Cooperative Group Report of 1463 Patients
- 5 January 2009
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 57 (2), 317-326
- https://doi.org/10.1016/j.eururo.2008.12.026
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Targeted drugs for metastatic renal cell carcinomaThe Lancet, 2008
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibThe Lancet, 2007
- Disparities in Treatment and Outcome for Renal Cell Cancer Among Older Black and White PatientsJournal of Clinical Oncology, 2007
- Impact of Immune Parameters on Long-Term Survival in Metastatic Renal Cell CarcinomaJournal of Clinical Oncology, 2006
- Randomized Phase II/III Trial of Interferon Alfa-2a With and Without 13-cis-Retinoic Acid in Patients With Progressive Metastatic Renal Cell Carcinoma: The European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group (EORTC 30951)Journal of Clinical Oncology, 2005
- Thirteen‐year, long‐term efficacy of interferon 2α and interleukin 2‐based home therapy in patients with advanced renal cell carcinomaCancer, 2002
- Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- Regimens With or Without Interferon-α as Treatment for Metastatic Melanoma and Renal Cell Carcinoma: An Overview of Randomized TrialsJournal of Immunotherapy, 1999
- Original Articles: Kidney Cancer: Renal Cell Carcinoma: Tumor Size, Stage and SurvivalJournal of Urology, 1995
- The Impact of Interleukin-2 on Survival in Renal Cancer: A Multivariate AnalysisCancer Biotherapy, 1993